Bhagwan Mahaveer Hospital & Research Center, Jaipur

Consultant in Medical Oncology

April 2021— Present

Apex Hospitals, Malviya Nagar Jaipur

Consultant Medical Oncology

August 2018 — April 2021

Tata Memorial Hospital Mumbai

Senior Registrar in Medical Oncology

1st august 2014 — 31st July 2018

Safdarjung Hospital, New Delhi

Senior Resident in Medical Oncology

31st july 2012 — 06th April 2014

• Dr. Sudeep Gupta – Professor medical oncology department, and Director, (CRC) ACTREC. sudeepgupta04@yahoo.com
• Dr. Shripad D Banavali - Academic director (Dean) Of Tata Memorial Hospital Mumbai. banavali_2000@yahoo.com
• Dr. NavinKhattry - Professor and BMT Program Coordinator, Department of MedicalOncology and Deputy Director, (CRC) ACTREC at Tata Memorial hospital. nkhattry@gmail.com
• Dr Kumar Prabhash - Professor and Head Department of at Tata Memorial hospital. kprabhash1@gmail.com
• Dr S.P. Katariya Head of Department of Medical Oncology, Safdarjung Hospital, New Delhi
• Dr Sachin Jhawar -CEO Apex Hospitals Malviya Nagar Jaipur. dr.sachinjhawar@apexhospitals.com

• Letter to Editor : Management of Ovarian Cancer. CRST DOI 10.4103/CRST.CRST_128_19
• Karpe A, Patil VM , Joshi A, Noronha V, Gupta S, Ramaswamy A , Sahu A , Doshi V , Gupta T, Rath S , Banavali S , Prabhash K . Weekly cisplatin (30-40 mg/m2) as radiosensitizer: Is it high or moderate emetic agent?: Indian J Cancer. 2016 Jul-Sep;53(3):454-456.
• Patil VM, Noronha V, Joshi A, Ramaswamy A , Gupta S, Sahu A , DoshiV ,Gupta T, Rath S , Banavali S , PrabhashK .Adherence to and Implementation of ASCO Antiemetic Guidelines in Routine Practice in a Tertiary Cancer Center in India: JOncolPract. 2017 Jun;13(6):e574-e581
• Trial ( awaiting for publication) - “ To study the Effect of structured teaching module on Capecitabine induced Hand –Foot syndrome in patients with Colorectal Cancer at Tertiary Care Centre.” A prospective randomized Control Trial.
• VikasOstwal, Tarachand Gupta , Supriya Chopra , Sherly Lewis , Mahesh Goel, Shraddha Patkar , Nitin Shetty , AnantRamaswamy .Tolerance and adverse event profile with Sorafenib in Indian patients with advanced hepatocellular carcinoma: South Asian J Cancer 2017;6:144-6
• AnantRamaswamy; RushabhKoathari; Ashwin Desouza; Tarachand Gupta; Sandeep Bairwa; Akhil Kapoor; Amit Kumar; Pradeep Ventrapati; MuktaRamadwar; SarikaMandavkar; Nita Chavan; AvanishSaklani; VIKAS OSTWAL. Adjuvant chemotherapy in stage II - III operated colon cancer patients from a non-trial cohort in a low colon cancer prevalence country and use of modified CAPOX. South Asian J Cancer
  Jul-Sep 2019;8(3):160-165.
  doi: 10.4103/sajc.sajc_176_18
• Thesis in M.D. “ Evaluation of various ischaemic end points response in patient subjects for stress test and its correlation with various risk factors.”
• Paper presentation on “ A study to compare the role of N-Acetyl Cysteine and combination of N-Acetyl Cysteine with Taurine in proteinuria in Diabetes mellitus” in UPDACON 2010 Jhansi
• Poster presentation titled “Association of Lipoprotein (A) in Patients of Acute Myocardial Infarction” in IACM Patna 2011
• Attended the ECG learning course, conducted by Indian Society of Electro cardiology on 6 th august 2011.

• 5 th rank in all India level entrance test of Tata Memorial Hospital for D.M. Medical oncology 2014
• Only candidate selected in July 2014 for PhD in medical oncology at AIIMS
• 771st Rank in all India entrance test for Medical post-graduation courses 2009
• 30 th Rank in Rajasthan Pre Medical Test 2001
• Gold medal in intracollege Carom championship in Mixed double category in 2004

• Organizing secretory of 2 days National webinar on genitourinary cancers GU Conundrum 2020, 24th and 25th September.
• Panelist in Session of Small Cell Lung Cancer in webinar of OncoWebex2020on 30th September 2020
• Chairperson in Session " Screening and early lung cancer " in lung cancer master class 19th July 2020
• Panelist in webinar of Breast Cancer Chakravyuh - Breaking Barriers In session on Her2 Neu MBC
• Chairperson in webinar of Best clinical oncology symposium 10th June 2020
• Panelist in “Update in Lung Cancer YER 2019”, Mumbai 20-22 December 2019
• Panelist in IBCC 2019 Jaipur in session on Multimodality treatment of LABC
• Moderator in Jaipur CME on lymphoma 19th July 2019 .
• Speaker : Abstract of Phase III Trial of Rd Followed by R vs Continuous Rd in Intermediate-Fit Elderly
• Patients With Newly Diagnosed Multiple Myeloma in Hematology update 2019" Jaipur. 05-01-2019
• Panelist in “Update in Lung Cancer YER 2018”, Mumbai 15th and 16th December 2018
• Chairperson in session 3of Lung Cancer in “UAE Cancer congress 2018” , Dubai 11th to 13th October 2018
• Quiz Master and Panelist in “ IBCC 2018” Jaipur.

• Head And Neck : A Phase II Clinical Study to evaluate the efficacy and safety of NRC-2694-A in patients with Recurrent Head and Neck Squamous cell Carcinoma.
• RCC-A Randomized, Open Label, Multi-Center, Two-Treatment, Two-Period, Two-Sequence, Two-Way Crossover, Multiple Dose, Steady-State Bioequivalence (BE) Study of Pazopanib HCL 200mg Tablets at a Dose of 800mg (4 * 200 mg tablets) of Lotus Pharmaceutical Co., Ltd., Taiwan with VOTRIENT® (Pazopanib HCL 200mg) Tablets at a Dose of 800 mg (4 * 200 mg tablets) of Novartis Pharmaceuticals Corporation, USA in Subjects with Advanced Renal Cell Carcinoma Under Fasting Condition
• Ongoing Biosimilar Trial (Recruitment Completed) :Randomized, Assessor- Blind, Multicentre,Parellel Group, Two Arms, Clinical Study to Assess the Efficacy, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety of Rituximab ( Test Product, Zydus) in comparision with Rituximab( Reference product, Roche/Genentech) in Patients with Diffuse Large B Cell Lymphoma (DLBCL).
• Ongoing Biosimilar Trial (Recruitment Completed) : A Prospective,Randomized, Multicenter Comparative, Open label ,Parellel Study to evaluate the Efficacy, Safety and Pharmacokinetics, of Test-Trastuzumab Emtansine ( ZRC3256;Cadila Healthcare Ltd) and Reference- Trastuzumab Emtansine(Kadcyla, Roche Products (India)Pvt.Ltd) in HER 2- Positive Metastatic Breast Cancer Patients